417 related articles for article (PubMed ID: 17610860)
1. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric identification of human phosphate cytidylyltransferase 1 as a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix.
Priyadarshini ; Singh SK; Tandon C
Clin Chim Acta; 2009 Oct; 408(1-2):34-8. PubMed ID: 19595683
[TBL] [Abstract][Full Text] [Related]
3. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
Srinivasan S; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
[TBL] [Abstract][Full Text] [Related]
4. Proteome of human calcium kidney stones.
Canales BK; Anderson L; Higgins L; Ensrud-Bowlin K; Roberts KP; Wu B; Kim IW; Monga M
Urology; 2010 Oct; 76(4):1017.e13-20. PubMed ID: 20709378
[TBL] [Abstract][Full Text] [Related]
5. 2D map of proteins from human renal stone matrix and evaluation of their effect on oxalate induced renal tubular epithelial cell injury.
Aggarwal KP; Tandon S; Singh SK; Tandon C
Int Braz J Urol; 2013; 39(1):128-36. PubMed ID: 23489505
[TBL] [Abstract][Full Text] [Related]
6. Novel antilithiatic cationic proteins from human calcium oxalate renal stone matrix identified by MALDI-TOF-MS endowed with cytoprotective potential: an insight into the molecular mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
Clin Chim Acta; 2013 Jan; 415():181-90. PubMed ID: 23123287
[TBL] [Abstract][Full Text] [Related]
7. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
[TBL] [Abstract][Full Text] [Related]
8. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
Khan SR; Glenton PA; Backov R; Talham DR
Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
[TBL] [Abstract][Full Text] [Related]
9. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the presence of abnormal proteins in the urine of recurrent stone formers.
Grover PK; Resnick MI
J Urol; 1995 May; 153(5):1716-21. PubMed ID: 7715017
[TBL] [Abstract][Full Text] [Related]
11. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
Atmani F; Lacour B; Daudon M
Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
[TBL] [Abstract][Full Text] [Related]
12. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
[TBL] [Abstract][Full Text] [Related]
13. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
Govindaraj A; Selvam R
BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
[TBL] [Abstract][Full Text] [Related]
14. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
[TBL] [Abstract][Full Text] [Related]
15. Effect of biomolecules from human renal matrix of calcium oxalate monohydrate (CaOx) stones on in vitro calcium phosphate crystallization.
Pathak P; Singh SK; Tandon C
Int Braz J Urol; 2010; 36(5):621-8. PubMed ID: 21044380
[TBL] [Abstract][Full Text] [Related]
16. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men.
Marengo SR; Resnick MI; Yang L; Chung JY
J Urol; 1998 May; 159(5):1444-50. PubMed ID: 9554330
[TBL] [Abstract][Full Text] [Related]
18. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
Atmani F; Khan SR
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
[TBL] [Abstract][Full Text] [Related]
20. Intracrystalline proteins and the hidden ultrastructure of calcium oxalate urinary crystals: implications for kidney stone formation.
Lyons Ryall R; Fleming DE; Doyle IR; Evans NA; Dean CJ; Marshall VR
J Struct Biol; 2001 Apr; 134(1):5-14. PubMed ID: 11469872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
